Cefotaxime is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceuticals Corp. The primary component is Cefotaxime Sodium.
Product ID | 0143-9935_e8783b78-0cd5-4f12-bcbc-be12631d4903 |
NDC | 0143-9935 |
Product Type | Human Prescription Drug |
Proprietary Name | Cefotaxime |
Generic Name | Cefotaxime |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2002-11-20 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA065071 |
Labeler Name | West-Ward Pharmaceuticals Corp |
Substance Name | CEFOTAXIME SODIUM |
Active Ingredient Strength | 10 g/1 |
Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2002-11-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA065071 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2002-11-20 |
Marketing Category | ANDA |
Application Number | ANDA065071 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2002-11-20 |
Marketing End Date | 2014-09-08 |
Ingredient | Strength |
---|---|
CEFOTAXIME SODIUM | 10 g/1 |
SPL SET ID: | ef1a6dc6-bc3d-4f09-8f92-7ff328f56561 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9930 | Cefotaxime | Cefotaxime |
0143-9931 | Cefotaxime | Cefotaxime |
0143-9933 | Cefotaxime | Cefotaxime |
0143-9935 | Cefotaxime | Cefotaxime |
21586-011 | Cefotaxime | cefotaxime injection |
21586-012 | Cefotaxime | cefotaxime injection |
55648-947 | CEFOTAXIME | CEFOTAXIME |
55648-948 | CEFOTAXIME | CEFOTAXIME |
55648-986 | CEFOTAXIME | CEFOTAXIME |
64679-947 | Cefotaxime | Cefotaxime |
64679-948 | Cefotaxime | Cefotaxime |
64679-986 | Cefotaxime | Cefotaxime |
68180-811 | CEFOTAXIME | CEFOTAXIME |
68180-822 | CEFOTAXIME | CEFOTAXIME |
68180-833 | CEFOTAXIME | CEFOTAXIME |